Innate Pharma(IPHA) - 2025 Q2 - Quarterly Report

INNATE PHARMA SA HALF-YEAR FINANCIAL REPORT JUNE 30, 2025 INNATE PHARMA S.A. French société anonyme governed by a Board of Directors with a share capital of 4,609,522.15 euros composed of 92,176,373 ordinary shares, and 14,070 preferred shares with a nominal value of 0.05 euros each Registered office: 117, Avenue de Luminy, F-13009 Marseille, France Registered with the Company and Trade Register of Marseille under number 424 365 336 The following interim condensed consolidated financial statements have been ...